Digital Health Coffee Time Briefing ☕

News

4 June 2026

September 18, 2025

Your morning summary of digital health news, information and events to know about if you want to be “in the know”.

👇 News

🎤 AI-powered health intelligence platform HaloScape has signed a strategic collaboration with Canary Speech, a US-based vocal biomarker technology company, to integrate voice analysis into HaloScape’s platform. The collaboration tracks mood, stress, vocal energy, wellness, and mild cognitive impairments to evaluate voice alongside other health data and uncover clinically meaningful insights.

🏆 Berkshire Healthcare NHS Foundation Trust is one of the first trusts in the country to achieve Advanced Foundation Trust status, a national mark of excellence from NHS England. The award recognises highly performing NHS organisations that consistently deliver excellent care, strong leadership, financial sustainability, and value for money, while also demonstrating the ability to improve health outcomes for the communities they serve.

💎 Preventive health platform Emerald has partnered with UK fitness and health network Epassi UK to enable businesses to offer help employees identify early health risk signals. Emerald combines in-clinic laboratory screening with ongoing private GP support and a digital platform that brings results, wearable data, and health history together in one place.

🏋️‍♂️ Fitness workforce management provider CoverMe has launched CoverMe PT, an on-demand personal training platform that quickly connects personal trainers and clients. CoverMe’s AI matching engine learns from every booking, cancellation, and session to help trainers reach clients without traditional in-gym sales techniques.

🧑‍🦼 Quality Compliance Systems has announced the acquisition of CareBrain, a technology transformation platform purpose-built for the care sector. CareBrain was founded by care and technology sector experts and addresses some of the most time-intensive challenges facing care teams, including care plan audits, supervisions, and round-the-clock guidance.

❓ Did you know that?

Researchers have revealed that subtle errors in a virtual-reality navigation task may predict hidden brain changes associated with neurodegenerative disease long before symptoms appear.

The study, published in Alzheimer’s Research & Therapy on 20 April 2026 and undertaken by researchers from Fujita Health University, Japan, found that poorer virtual-reality path integration (VR-PI) performance in cognitively healthy adults was linked to accelerated cortical thinning in Alzheimer’s-vulnerable brain regions and elevated blood biomarkers of neurodegeneration.

Poorer VR navigation performance was associated with structural decline in regions vulnerable to early Alzheimer’s disease, including the parahippocampal gyrus, posterior cingulate cortex, and middle temporal gyrus.

Higher navigation errors were linked to increased levels of Alzheimer’s-related blood biomarkers, including p-tau181 and GFAP, suggesting measurable biological changes before clinical symptoms emerge.

The findings, researchers claim, point to a potential non-invasive, early detection tool for identifying neurodegenerative risk in cognitively healthy individuals.

📖 What we’re reading

Andy Kinnear, former NHS CIO and now an independent consultant, has written about the NHS Digital Maturity Assessment (DMA), which measures how NHS organisations are progressing on their digital transformation journeys.

Kinnear delves into the results from the 2024 and 2025 assessments and says the NHS is in a strong position to advance digital transformation and should ensure that these measurements translate into meaningful, sustained improvement.

He said: “When it comes to the digital space, our ability to measure, analyse, and act has been very inconsistent.

“Down the decades, attempts to assess digital progress, understand efficacy of investment, and hold those responsible for delivery to account have largely come and gone, often treated with some level of derision from frontline leaders who see these tools as levers for investment or short-term annoyances unlikely to yield long-term benefits.”